Search

A new drug for ovarian cancer, which was developed based on lab research at MSK, is transforming the possibilities for patients like Ellen Coopersmith.

… Thursday, September 11, 2025 VIDEO | 02:38 Watch How a Lab Discovery Sparked New Treatment for Rare Ovarian Cancer Every cancer breakthrough begins years before it offers patients new hope. Our series Saved by Science takes you inside MSK’s world class research labs, where you’ll see patients meet the

The Thoracic Surgery Oncology Group (TSOG) is a joint initiative between the American Association for Thoracic Surgery and the Fiona & Stanley Druckenmiller Center for Lung Cancer Research at Memorial Sloan Kettering Cancer Center (MSK).

… Friday, March 15, 2024 The Thoracic Surgery Oncology Group (TSOG) is a joint initiative between the  American Association for Thoracic Surgery and the  Fiona & Stanley Druckenmiller Center for Lung Cancer Research at Memorial Sloan Kettering Cancer Center (MSK). TSOG is a network of thoracic surgeons

The Peritoneal Surface Malignancies Consortium Group is a national, multidisciplinary collaboration of surgical and medical gastrointestinal oncology specialists from top cancer centers. The group recently published a series of updated consensus guidelines for the clinical management of peritoneal metastases related to a variety of gastrointestinal malignancies. In this Q&A with Dr. Michael Foote we discuss discuss the major updates for the management of colorectal cancer and appendiceal cancer peritoneal metastases and how the changes will improve patient outcomes and streamline patient care.

… Tuesday, December 23, 2025 A Q&A with  Michael Foote, MD , MSK Gastrointestinal Medical Oncologist and member of the Peritoneal Surface Malignancies Consortium Group The Peritoneal Surface Malignancies Consortium Group (PSM Consortium Group) is a national, multidisciplinary collaboration of surgical

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, August 31, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Vinod Balachandran Awarded the 2023 FNIH Trailblazer Prize for Clinician-Scientists Vinod Balachandran, MD , hepatopancreatobiliary surgeon, was awarded the  2023 Trailblazer

MSK patients will remain in-network to continue receiving world-class cancer care.

… Tuesday, July 1, 2025 Memorial Sloan Kettering Cancer Center (MSK) and United Healthcare (UHC) today announced a new, multi-year agreement that ensures continued in-network access to MSK for UHC’s commercial members. As a result, current and new UHC-insured patients can continue to receive care at MSK

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce TIME has named two MSK physician-scientists, Andrea Cercek, MD, and Vinod Balachandran, MD, to the 2025 TIME100 Health, a list of the 100 most influential individuals in health.

… Thursday, May 8, 2025 Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce TIME has named two MSK physician-scientists, Andrea Cercek, MD , and Vinod Balachandran, MD , to the 2025 TIME100 Health , a list of the 100 most influential individuals in health. Dr. Cercek is recognized for her

With the power of advanced microscopes, Sloan Kettering Institutes scientists are pushing the boundaries of what can be seen and measured.

… Wednesday, May 26, 2021 VIDEO | 00:25 A Developing Mouse Embryo This movie from the Kat Hadjantonakis lab shows an 11-day-old mouse embryo with its internal organs labeled in different fluorescence. The video was prepared by postdoc Evan Bardot. Video Details If you’ve ever explored Google Earth, you

MSK is a leader in developing new types of immunotherapy for gynecologic cancers, including tumors of the cervix, ovaries, and uterus.

… Wednesday, September 30, 2020 Summary MSK currently has a number of trials investigating the use of T cell therapies in gynecologic therapy — an approach that’s beginning to show promise in treating these and other solid tumors. The American Cancer Society estimates that more than 113,000 people in the

Stephen B. Long, PhD will share “Something Completely Different” during the June 17 edition of “MSK Science Spotlight” – the Structure and Mechanism in the Calcium-Activated Chloride Channel BEST1.

… Wednesday, June 17, 2020 Stephen B. Long , PhD will share “Something Completely Different” during the June 17 edition of “ MSK Science Spotlight ” – the Structure and Mechanism in the Calcium-Activated Chloride Channel BEST1. Head of the Stephen Long Lab and Member of the Structural Biology Program at

There are many types of coronaviruses. The type of coronavirus in the news right now is called COVID-19. COVID-19 causes mild to severe respiratory (breathing) problems. It can cause serious problems, especially in older people and people with other health problems, including cancer.

… Friday, April 17, 2020 There are many types of coronaviruses. The type of coronavirus in the news right now is called COVID-19. COVID-19 causes mild to severe respiratory (breathing) problems. It can cause serious problems, especially in older people and people with other health problems, including cancer